Literature DB >> 18400058

Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder.

Hunna J Watson1, Clare S Rees.   

Abstract

OBJECTIVE: To conduct a meta-analysis on randomized, controlled treatment trials of pediatric obsessive-compulsive disorder (OCD).
METHOD: Studies were included if they employed randomized, controlled methodology and treated young people (19 years or under) with OCD. A comprehensive literature search identified 13 RCTs containing 10 pharmacotherapy to control comparisons (N = 1016) and five cognitive-behavioral therapy (CBT) to control comparisons (N = 161).
RESULTS: Random effects modeling yielded statistically significant pooled effect size (ES) estimates for pharmacotherapy (ES = .48, 95% CI = .36 to .61, p < .00001) and CBT (ES = 1.45, 95% CI = .68 to 2.22, p = .002). The results were robust to publication bias.
CONCLUSIONS: This is the first meta-analysis of treatment RCTs for pediatric OCD. CBT and pharmacotherapy were the only treatments effective beyond control in alleviating OCD symptoms. CBT showed a greater ES than pharmacotherapy. Previous meta-analyses that included uncontrolled trials exaggerated the efficacy of both treatments.

Entities:  

Mesh:

Year:  2008        PMID: 18400058     DOI: 10.1111/j.1469-7610.2007.01875.x

Source DB:  PubMed          Journal:  J Child Psychol Psychiatry        ISSN: 0021-9630            Impact factor:   8.982


  54 in total

1.  Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial.

Authors:  Martin E Franklin; Jeffrey Sapyta; Jennifer B Freeman; Muniya Khanna; Scott Compton; Daniel Almirall; Phoebe Moore; Molly Choate-Summers; Abbe Garcia; Aubrey L Edson; Edna B Foa; John S March
Journal:  JAMA       Date:  2011-09-21       Impact factor: 56.272

2.  Family factors predict treatment outcome for pediatric obsessive-compulsive disorder.

Authors:  Tara S Peris; Catherine A Sugar; R Lindsey Bergman; Susanna Chang; Audra Langley; John Piacentini
Journal:  J Consult Clin Psychol       Date:  2012-02-06

3.  Side-effects of SSRIs disrupt multimodal treatment for pediatric OCD in a randomized-controlled trial.

Authors:  Adam M Reid; Joseph P H McNamara; Tanya K Murphy; Andrew G Guzick; Eric A Storch; Wayne K Goodman; Gary R Geffken; Regina Bussing
Journal:  J Psychiatr Res       Date:  2015-10-14       Impact factor: 4.791

4.  Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention.

Authors:  Joseph F McGuire; Adam B Lewin; Daniel A Geller; Ashley Brown; Kesley Ramsey; Jane Mutch; Andrew Mittelman; Jamie Micco; Cary Jordan; Sabine Wilhelm; Tanya K Murphy; Brent J Small; Eric A Storch
Journal:  Neuropsychiatry (London)       Date:  2012-08

5.  Obsessive-compulsive disorder: Evidence-based treatments and future directions for research.

Authors:  Caleb W Lack
Journal:  World J Psychiatry       Date:  2012-12-22

Review 6.  A compensatory role for declarative memory in neurodevelopmental disorders.

Authors:  Michael T Ullman; Mariel Y Pullman
Journal:  Neurosci Biobehav Rev       Date:  2015-01-15       Impact factor: 8.989

7.  A META-ANALYSIS OF COGNITIVE BEHAVIOR THERAPY AND MEDICATION FOR CHILD OBSESSIVE-COMPULSIVE DISORDER: MODERATORS OF TREATMENT EFFICACY, RESPONSE, AND REMISSION.

Authors:  Joseph F McGuire; John Piacentini; Adam B Lewin; Erin A Brennan; Tanya K Murphy; Eric A Storch
Journal:  Depress Anxiety       Date:  2015-06-30       Impact factor: 6.505

Review 8.  Pediatric indications for deep brain stimulation.

Authors:  Matthew F DiFrancesco; Casey H Halpern; Howard H Hurtig; Gordon H Baltuch; Gregory G Heuer
Journal:  Childs Nerv Syst       Date:  2012-07-25       Impact factor: 1.475

9.  D-Cycloserine augmentation of cognitive behavior therapy for pediatric OCD: Predictors and moderators of outcome.

Authors:  Sabine Wilhelm; Noah Berman; Brent J Small; Rachel Porth; Eric A Storch; Daniel Geller
Journal:  J Affect Disord       Date:  2018-07-20       Impact factor: 4.839

10.  Does d-Cycloserine Augmentation of CBT Improve Therapeutic Homework Compliance for Pediatric Obsessive-Compulsive Disorder?

Authors:  Jennifer M Park; Brent J Small; Daniel A Geller; Tanya K Murphy; Adam B Lewin; Eric A Storch
Journal:  J Child Fam Stud       Date:  2014-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.